Rhabdomyosarcoma: Clinical Trials

10 trials for Rhabdomyosarcoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 terminated. 10 Phase 2, 4 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 210Terminated 10
Phase 14Terminated 4

Follow Rhabdomyosarcoma: new trials by email Literature Review of Rhabdomyosarcoma trials Research Report on Rhabdomyosarcoma

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Bempegaldesleukin (BEMPEG: NKTR-214) in Combination With Nivolumab in Children, Adolescents and Young Adults With Recurrent or Treatment-resistant Cancer
Nivolumab, NKTR-214 - Ependymoma, Ewing Sarcoma
Phase 1 / Phase 2TerminatedBristol-Myers Squibb152021-06-032023-03-24
Donor Stem Cell Transplant After Chemotherapy for the Treatment of Recurrent or Refractory High-Risk Solid Tumors in Pediatric and Adolescent-Young Adults
Allogeneic Hematopoietic Stem Cell Transplantation, Cyclosporine, Etoposide - Desmoplastic Small Round Cell Tumor, Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor
Phase 2TerminatedM.D. Anderson Cancer Center12020-08-192025-06-29
Safety, Tolerability, Efficacy and Pharmacokinetics of Copanlisib in Pediatric Patients
Copanlisib (BAY806946) - Relapsed or Refractory Solid Tumors or Lymphoma in Children, Neuroblastoma
Phase 1 / Phase 2TerminatedBayer312018-04-302023-12-04
Insulin-like Growth Factor 1 Receptor (IGF-1R) Antibody AMG479 (Ganitumab) in Combination With the Src Family Kinase (SFK) Inhibitor Dasatinib in People With Embryonal and Alveolar Rhabdomyosarcoma
Dasatinib, Ganitumab - Rhabdomyosarcoma, Rhabdomyosarcoma, Alveolar
Phase 1 / Phase 2TerminatedNational Cancer Institute (NCI)142017-07-072022-04-14
Stereotactic Body Radiotherapy (SBRT) for Pulmonary Metastases in Ewing Sarcoma, Rhabdomyosarcoma, and Wilms Tumors
Stereotactic Body Radiotherapy (SBRT) - Ewing Sarcoma, Rhabdomyosarcoma
Phase 1 / Phase 2TerminatedDana-Farber Cancer Institute52017-01-012021-04-30
Study of Genistein in Pediatric Oncology Patients (UVA-Gen001)
Genistein, Placebo - Lymphoma, Childhood Lymphoma
Phase 2TerminatedUniversity of Virginia42016-08-012024-05-06
Phase 2 STIR Trial: Haploidentical Transplant and Donor Natural Killer Cells for Solid Tumors
Allogeneic HCT, Donor NK Cell Infusion - Ewing Sarcoma, Neuroblastoma
Phase 2TerminatedMonica Thakar152013-03-202025-03-19
Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Stage IB, Stage II, or Stage III Soft Tissue Sarcoma
gene expression analysis, polymerase chain reaction, western blotting - Sarcoma
Phase 2TerminatedCity of Hope Medical Center12008-07-012014-07-11
Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant
anti-thymocyte globulin, rituximab, clofarabine - Cancer
Phase 2TerminatedMasonic Cancer Center, University of Minnesota122008-01-012017-12-28
S9624 Ifosfamide in Treating Patients With Meningeal Tumors
ifosfamide - Chondrosarcoma, Adult Fibrosarcoma
Phase 2TerminatedSWOG Cancer Research Network71998-07-012013-11-08

Narrower conditions

Neuroblastoma (6)  ·  Sarcoma, Ewing (5)  ·  Lymphoma (3)  ·  Lymphoma, Non-Hodgkin (3)  ·  Neoplasms (3)  ·  Osteosarcoma (3)  ·  Recurrence (3)  ·  Sarcoma (3)  ·  Wilms Tumor (3)  ·  Brain Neoplasms (2)  ·  Fibrosarcoma (2)  ·  Hodgkin Disease (2)  ·  Medulloblastoma (2)  ·  Neuroectodermal Tumors, Primitive, Peripheral (2)

Broader conditions

Myosarcoma (10)  ·  Neoplasms by Histologic Type (10)  ·  Neoplasms, Connective and Soft Tissue (10)  ·  Neoplasms, Muscle Tissue (10)  ·  Neoplasms, Nerve Tissue (9)  ·  Neoplasms, Connective Tissue (8)  ·  Neoplasms (7)  ·  Neoplasms, Glandular and Epithelial (7)  ·  Neoplasms, Neuroepithelial (7)  ·  Neuroectodermal Tumors (7)  ·  Sarcoma (7)  ·  Neoplasms by Site (6)  ·  Neoplasms, Germ Cell and Embryonal (6)  ·  Neuroectodermal Tumors, Primitive (6)  ·  Neoplasms, Bone Tissue (5)

Interventions

Antilymphocyte Serum (2)  ·  Stem Cell Transplantation (2)  ·  thymoglobulin (2)  ·  Blotting, Western (1)  ·  Bone Marrow Transplantation (1)  ·  Clofarabine (1)  ·  Cyclosporine (1)  ·  Cyclosporins (1)  ·  Dasatinib (1)  ·  Etoposide (1)  ·  Gene Expression Profiling (1)  ·  Genistein (1)  ·  IL32 protein, human (1)  ·  Ifosfamide (1)  ·  Immunotherapy, Adoptive (1)

Sponsors

Bayer (1)  ·  Bristol-Myers Squibb (1)  ·  City of Hope Medical Center (1)  ·  Dana-Farber Cancer Institute (1)  ·  M.D. Anderson Cancer Center (1)  ·  Masonic Cancer Center, University of Minnesota (1)  ·  Monica Thakar (1)  ·  National Cancer Institute (NCI) (1)  ·  SWOG Cancer Research Network (1)  ·  University of Virginia (1)

Countries

United States (10)  ·  Australia (2)  ·  France (1)  ·  Germany (1)  ·  Italy (1)  ·  Peru (1)  ·  Puerto Rico (1)  ·  Spain (1)

Top investigators

Christine M Heske, M.D. (1)  ·  Jakub Tolar, MD (1)  ·  Jeremy S Connors, MD (1)  ·  Karen Marcus, MD (1)  ·  Leslie McAllister, MD (1)  ·  Lynn G. Feun, MD (1)  ·  Monica Thakar, MD (1)  ·  Richard D. Pezner, MD (1)  ·  William C. Petersen, Jr., M.D. (1)

Results publications

PMID 31401903, PMID 33305087, PMID 37398992

NIH funding

2017 (1), P30CA033572 (1), U10CA032102 (1)